Viagra’s Patent Expires in Brazil. Market Is Flooded With Cheap Generic Pills

Viagra The day after Pfizer Inc’s patent for Viagra expired in Brazil, Carlos Sanchez flooded pharmacies with his generic erectile dysfunction pills. It was a day his army of lawyers, researchers and marketers had been preparing for more than three years, even winning a bid to move up the patent’s expiration date.

At a cost of 10 Reais (about US$ 4), Sanchez’s pills were five reais cheaper than Pfizer’s, which had cut its prices in half just weeks before the patent ended.

Sanchez’s copy of the little blue pill gave him an early foothold into the market for erectile dysfunction medicine in Brazil, where sales have quintupled in the last four years.

Consumers from an emerging middle class that pay for two-thirds of drug costs out of pocket tend to choose generics at the drug counter.

IMS Health (IMS) forecasts the industry will grow by 10% annually through 2019, as government subsidies for drug purchases and financing for innovation from Brazil’s state development bank offset economic growth that slowed to 2.2% in 2013, according to Geraldo Biasoto, economist at Universidade Estadual de Campinas.

While Brazil’s pharmaceutical industry isn’t known as a hotbed of innovation  –  Sanchez invests about half as much as Pfizer in research and development as a percentage of revenues – it hasn’t stopped drug copycats such as Sanchez from becoming billionaires.

Since taking over his family’s drug-store business at age 26, Sanchez has turned EMS Participacoes SA into a pharmaceutical company with revenue of two billion reais in 2013.

His net worth is valued at 2.9 billion, according to the Bloomberg Billionaires Index, including an art collection funded by years of dividends.

Maurizio Billi, the majority shareholder of the third-largest Brazilian drug producer, Eurofarma Laboratorios Ltda, has amassed a fortune worth more than 1.2 billion, while Ache Laboratorios Farmaceuticos SA, a Sao Paulo-based company that had sales of 1.9 billion Reais in 2013, has made billionaire fortunes for its three major shareholders, the Depieri, Baptista and Siaulys families.

Eurofarma and EMS are surpassed in scale by Laboratorio Neo Quimica, the pharmaceutical unit of consumer goods company Hypermarcas SA, which had revenue of 2.3 billion reais last year.

The two companies are the second- and third-biggest producers of sildenafil citrate pills in Brazil, trailed by Pfizer in sixth place, according to IMS Health.

EMS exports to more than 40 countries in Latin America, Europe, Africa and Asia.

Mercopress

Tags:

  • Show Comments (0)

Your email address will not be published. Required fields are marked *

comment *

  • name *

  • email *

  • website *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Ads

You May Also Like

In Brazil, Inequality Is a Heirloom Passed from One Generation to the Next

Why are there rich and poor countries? Why are there rich and poor continents? ...

Election Campaign Has Started in Brazil. Even Most Corrupt Are Again Candidates

The political season is on in Brazil. Starting Tuesday, is now legal to campaign ...

NGO Urges Brazil to Control Haiti’s Police

Brazil’s Minister of the Special Secretariat for Human Rights, Nilmário Miranda, had a meeting ...

A Brazilian Step to Become World Reference in Heart Treatment

Brazilian President Luiz Inácio Lula da Silva was in São Paulo, this past Friday, ...

Brazil and Neighbors Ask for Help to End Foot and Mouth Disease

The mutual effort by the member countries of the Southern Agricultural Council (CAS) to ...

‘I Defend a Palestinian State and Israel,’ Says Brazil’s Lula

The result of the Summit of South American – Arab Countries will come “in ...

Brazil Hosts Local Development Expo

Representatives of Brazil, Chile, Spain, Portugal, Mozambique, Guinea-Bissau, and Cape Verde, together with international ...

One Land Management Accord for Brazil and Six Portuguese-Speaking Countries

A concrete result of the 2nd International Conference on Agrarian Reform and Rural Development ...

What Brazil Has to Teach the US on AIDS

Dr. Richard Parker of Columbia University visited University of Illinois at Chicago (UIC) on ...

US Taxes Brazilian Shrimp. Brazil Reacts Cheerily.

Brazilian shrimp are subject to a 10.4% surcharge on exports to the United States, ...